Litcius/Paper detail

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial

Bruce L. Wilkoff, Gerasimos Filippatos, Christophe Leclercq, Michael R. Gold, Ahmad Hersi, Kengo Kusano, Wilfried Müllens, G. Michael Felker, Charan Kantipudi, Mikhael F. El‐Chami, Vidal Essebag, Bertrand Pierre, François Philippon, Francisco Perez-Gil, Eugene Chung, Juan C. Sotomonte, Stanley Tung, Balbir Singh, Babak Bozorgnia, Satish Goel, H Ebert, Niraj Varma, Kara J. Quan, Fiorella Salerno, Bart Gerritse, Janelle van Wel, Daniel E. Schaber, Dedra H. Fagan, David H. Birnie

2023The Lancet61 citationsDOI

Topics & Concepts

MedicineLeft bundle branch blockHeart failureBundle branch blockCardiologyEjection fractionInternal medicineQRS complexPopulationCardiac resynchronization therapyHeart blockDecompensationElectrocardiographyEnvironmental healthCardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementMechanical Circulatory Support Devices
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial | Litcius